Methylglyoxal modification of LDL: proatherogenicity without oxidation opens new paths to prevent cardiovascular disease-Reference-Cited by-同舟云学术

Methylglyoxal modification of LDL: proatherogenicity without oxidation opens new paths to prevent cardiovascular disease

Published:2011-12-01 Issue:6 Volume:6 Page:631-634
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Thornalley Paul¹,Rabbani Naila

Affiliation:

1. Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, University Hospital, Clifford Bridge Road, Coventry, CV2 2DX, UK

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.11.53

Reference24 articles.

1. Bitton A, Gaziano T. The Framingham heart study’s impact on global risk assessment. Prog. Cardiovasc. Dis. 53, 68–78 (2010)

2. Sarwar N, Gao P, Seshasai SRK et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215–2222 (2010)

3. Rizzo M, Berneis K, Corrado E, Novo S. The significance of low-density-lipoproteins size in vascular diseases. Int. Angiolo. 25, 4–9 (2011)

4. Rizzo M, Berneis K, Koulouris S et al. Should we measure routinely oxidized and atherogenic dense low-density lipoproteins in subjects with Type 2 diabetes? Int. J. Clin. Prac. 64, 1632–1642 (2010)

5. Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler. Thromb. Vasc. Biol. 17,2507–2514 (1997)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylglyoxal – An emerging biomarker for diabetes mellitus diagnosis and its detection methods;Biosensors and Bioelectronics;2019-05

2. 3-(10′-Phenothiazinyl)propionic acid is a potent primary enhancer of peroxidase-induced chemiluminescence and its application in sensitive ELISA of methylglyoxal-modified low density lipoprotein;Talanta;2013-10

3. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes;Vascular Health and Risk Management;2013-10